• Wion
  • /World
  • /Johnson & Johnson vaccines to be restarted in US despite rare clot risk

Johnson & Johnson vaccines to be restarted in US despite rare clot risk

US has approved to restart of Johnson & Johnson COVID-19 vaccine roll out after scientific advisers decided its benefits outweigh a rare risk of blood clot.